Syneika

Syneika is a French manufacturer of medical equipment designed for care using Transcranial Magnetic Stimulation (TMS), a neuromodulation technology used for therapeutic purposes in a neurological or psychiatric context.

The result of more than 15 years of collaboration with caregivers and imaging research teams, Syneika is at the origin of the Syneika One neuronavigator, an innovative piece of equipment that allows each TMS user to precisely stimulate the right area of the cerebral cortex.

Syneika is the French distributor of PowerMAG TMS stimulators (Mag&More, Munich) and offers complete services and solutions to implement and support efficient and perfectly controlled therapeutic activity.

As a partner of healthcare teams in the management of widespread chronic pathologies, Syneika works to ensure that every patient concerned has access to quality TMS treatment.

Syneika is an ISO 13485:2016 certified company.
The Syneika One neuronavigator is a regulated health product and is CE marked (class IIb) in accordance with these regulations.

Since its launch, the Syneika One neuronavigator has been used to accurately treat 10,000 patients in 150,000 sessions of neuronavigated transcranial magnetic stimulation.

Syneika's mission is to enable the greatest number of patients suffering from chronic neurological or psychiatric pathologies to have access to the best possible care through neurostimulation.

From the very beginning of our project, doctors, researchers and engineers have worked together to provide each patient with an effective and individualised treatment. The work done since then tends to make the most advanced medical techniques accessible to all.

Syneika has implemented a Quality Management System to pursue these objectives, to satisfy the needs of its customers in compliance with the regulations and to continuously improve its performance.

This Quality Management System is compliant with the ISO 13485:2016 standard and with the 93/42/EEC directive on the placing on the market of medical devices. Syneika is actively preparing for the implementation of the requirements of the new Medical Device Regulation (Regulation 2017/745) and is already applying the "Transitional Provisions" of Article 120 of this Regulation.